Αρχειοθήκη ιστολογίου

Πέμπτη 5 Οκτωβρίου 2017

Risk of Infection in Patients with Atopic Dermatitis Treated with Dupilumab: A Meta-Analysis of Randomized Controlled Trials

Atopic dermatitis (AD) is characterized by skin barrier defects, Th2 activation, and increased risk for cutaneous and extracutaneous infections. In clinical trials, dupilumab appeared to decrease rates of skin infections in AD.

http://ift.tt/2y1PvVz

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου